Uzbekistan Opens 60-Day Fast Track for Ultrasound Metrics

On June 18, 2026, Uzbekistan’s Ministry of Health announced a green pre-review channel for Ultrasound Metrics products, cutting the registration period to 60 calendar days from 180 for eligible B-mode ultrasound systems, portable ultrasound devices, and AI-assisted diagnostic modules. For manufacturers, exporters, regulatory teams, distributors, and procurement-facing businesses, this is worth close attention because it changes the approval timeline while also recognizing Chinese NMPA Class II and above registration certificates as equivalent supporting documentation.

What the new pathway covers

According to the announced measure, the fast-track applies to Ultrasound Metrics products that meet IEC 61343-2:2025 and ISO 13485:2016 requirements. The eligible product scope includes B-mode ultrasound equipment, portable ultrasound instruments, and AI-assisted diagnostic modules. Uzbekistan’s Ministry of Health stated that products entering this green pre-review channel may obtain registration within 60 calendar days, compared with the previous 180-day cycle.

The same channel also accepts China NMPA Class II and higher registration certificates as equivalence support documents. Based on the provided information, these are the confirmed elements of the policy announcement made on June 18, 2026.

Where the immediate business impact may appear

For device manufacturers and export-oriented suppliers

Analysis shows that the most direct effect is likely to be felt by companies already producing compliant ultrasound-related products within the stated categories. A shorter registration cycle can affect launch sequencing, product filing preparation, and market-entry timing. What deserves closer attention is whether existing technical files, quality system documentation, and product certifications are already aligned with the standards and document expectations named in the announcement.

For regulatory and market access teams

From an industry perspective, regulatory teams may be among the first business functions to adjust. The acceptance of NMPA Class II and above certificates as equivalence support may influence dossier strategy, document translation planning, and submission scheduling for companies active in both China and Uzbekistan-related pathways. The practical impact will depend on how supporting materials are interpreted and applied in actual filings.

For distributors and local channel partners

Observably, distributors and channel operators may need to reassess product pipelines and customer communication timelines. If a product falls within the listed categories and meets the stated standards, local partners may be able to revise registration expectations, stock planning assumptions, and project coordination with healthcare buyers. The main point to monitor is whether faster approval in principle translates smoothly into local commercial rollout.

For procurement-facing businesses and service providers

Service providers involved in registration support, document handling, and delivery coordination may also see workflow changes. A shorter official cycle can compress preparation windows upstream, which means the accuracy of certificates, quality records, and supporting materials may become more important in day-to-day execution. For procurement-facing teams, the change mainly matters as a timing issue rather than as proof of guaranteed supply or immediate purchasing outcomes.

What companies should monitor now

Check whether products clearly fit the stated scope

Companies should first verify whether their offerings fall within the confirmed categories: B-mode ultrasound devices, portable ultrasound systems, and AI-assisted diagnostic modules. The policy should not be applied more broadly than the announcement supports.

Prepare documentation around the named standards

The announcement specifically references IEC 61343-2:2025 and ISO 13485:2016. In practical terms, businesses should review whether their certification status, technical records, and submission materials can support claims of compliance in a form suitable for registration use.

Assess how NMPA equivalence support works in practice

What deserves closer attention is the distinction between a supportive policy signal and actual filing execution. Although NMPA Class II and above certificates are accepted as equivalence support documents, companies still need to watch for any further clarification on how these documents are matched to product scope, module type, and submission completeness.

Align internal timelines with a shorter review cycle

A 60-day pathway can shorten official review time, but it can also expose delays in internal approvals, dossier preparation, translation, and local coordination. For that reason, exporters, regulatory service partners, and sales teams should treat timeline management as an operational issue rather than only a policy headline.

How this announcement is best understood at this stage

Analysis shows that this development is more meaningful as a market-access signal than as a complete indicator of commercial outcome. The confirmed change is the existence of a faster registration channel and the acceptance of specified supporting documentation for defined product types. It does not, by itself, confirm broader demand expansion, guaranteed approvals, or uniform implementation outcomes across all applicants.

It is more appropriate to understand this as a concrete short-term procedural change with possible longer-term signaling value. The shorter cycle and recognition of NMPA documentation suggest closer attention to compliance-based entry efficiency, especially for companies already positioned with the required certifications. At the same time, the industry still needs to observe how consistently the pathway operates in real submissions.

Why the market should keep watching

This update matters because it affects the intersection of product compliance, registration timing, and cross-border documentation strategy in the ultrasound device segment. For businesses already active in eligible categories, the announcement may create a clearer route for planning submissions and coordinating local market entry. For the wider industry, however, the significance should still be read with discipline: the policy is specific, technical, and limited to the scope described in the announcement.

At present, the most balanced conclusion is that Uzbekistan’s move should be viewed as a relevant regulatory efficiency signal for eligible Ultrasound Metrics products, while the depth of its long-term market impact still requires continued observation.

Basis of this article and follow-up points

This article is based on the user-provided news title, event date, and event summary. It does not rely on any additional unverified data, market figures, company statements, or external links.

For developments of this kind, relevant source types usually include official government announcements, company disclosures, industry association updates, authoritative media reports, and standard-setting organization documents. A specific official source link was not provided in the input, so further verification remains necessary. Continued monitoring should focus on any later official clarification regarding filing details, document application standards, and execution in actual registration cases.